Advertisement
Advertisement
U.S. Markets close in 18 mins
Advertisement
Advertisement
Advertisement
Advertisement

Centogene N.V. (CNTG)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.77-0.58 (-9.08%)
As of 03:33PM EST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • Zacks

    Centogene N.V. (CNTG) Reports Q3 Loss, Tops Revenue Estimates

    Centogene N.V. (CNTG) delivered earnings and revenue surprises of -83.05% and 11.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    CENTOGENE Reports Third Quarter 2021 Financial Results

    Second Consecutive Quarter of Core Business Growth, Phasing Out COVID-19 Testing and Restructuring Organization for Core Rare Disease BusinessCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced financial results for the third quarter ended September 30, 2021, and provided a recent business update. Ex

  • GlobeNewswire

    CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021

    CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial results for the quarter ended September 30, 2021, on Wednesday, November 24, 2021, and will host a conference call and webcast to discuss these results at 2 p.m. CET / 8 a.m. ET that day. Participants may register i

Advertisement
Advertisement